These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6991095)

  • 1. Treatment of advanced colon cancer with 5-fluorouracil (NSC19893) versus cyclophosphamide (NSC26271) plus 5-fluorouracil: prognostic aspects of the differential white blood cell count.
    Chlebowski RT; Silverberg I; Pajak T; Weiner J; Kardinal C; Bateman JR
    Cancer; 1980 May; 45(9):2240-4. PubMed ID: 6991095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide plus 5-FU versus 5-FU alone in advanced gastric carcinoma.
    Chlebowski RT; Weiner JM; Silverberg I; Glass A; Bateman JR
    Oncology; 1985; 42(3):141-3. PubMed ID: 3889759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
    Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
    Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
    Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
    Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
    Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
    Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
    Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
    J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.
    Erlichman C; Fine S; Wong A; Elhakim T
    J Clin Oncol; 1988 Mar; 6(3):469-75. PubMed ID: 3280741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group.
    Colucci G; Maiello E; Gebbia V; Giuliani F; Serravezza G; Lelli G; Leo S; Filippelli G; Nicolella G; Brandi M
    Cancer; 1999 Feb; 85(3):535-45. PubMed ID: 10091727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy in stage III colon cancer with 5-fluorouracil and levamisole versus 5-fluorouracil and leucovorin.
    Dencausse Y; Hartung G; Sturm J; Kopp-Schneider A; Hagmüller E; Wojatschek C; Lindemann H; Fritze D; Queisser W
    Onkologie; 2002 Oct; 25(5):426-30. PubMed ID: 12415196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.
    Kemeny N; Israel K; Niedzwiecki D; Chapman D; Botet J; Minsky B; Vinciguerra V; Rosenbluth R; Bosselli B; Cochran C
    J Clin Oncol; 1990 Feb; 8(2):313-8. PubMed ID: 2405107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.
    Lokich JJ; Ahlgren JD; Gullo JJ; Philips JA; Fryer JG
    J Clin Oncol; 1989 Apr; 7(4):425-32. PubMed ID: 2926468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.
    Arkenau HT; Rettig K; Porschen R
    Int J Colorectal Dis; 2005 May; 20(3):258-61. PubMed ID: 15549327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin.
    Park RC; Blom J; Disaia PJ; Lagasse LD; Blessing JA
    Cancer; 1980 May; 45(10):2529-42. PubMed ID: 7378989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
    Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
    Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of advanced colorectal carcinoma with 5-fluorouracil and cyclophosphamide in combination with either CCNU or methotrexate.
    White DR; Richards F; Muss HB; Cooper MR; Spurr CL
    Cancer; 1980 Feb; 45(4):662-5. PubMed ID: 6986968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trial.
    Abad A; Garcia P; Gravalos C; Tusquets I; Font A; Perez G; Cortés-Funes H; Fabregat X; Barnadas A; Rosell R
    Cancer; 1995 Mar; 75(6):1238-44. PubMed ID: 7882275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: the Pan-European Trial in Adjuvant Colon Cancer 2 study.
    Köhne CH; Bedenne L; Carrato A; Bouché O; Popov I; Gaspà L; Valladares M; Rougier P; Gog C; Reichardt P; Wils J; Pignatti F; Biertz F
    Eur J Cancer; 2013 May; 49(8):1868-75. PubMed ID: 23571150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma. A comparative trial with 6-thioguanine.
    Presant CA; Denes AE; Liu C; Bartolucci AA
    Cancer; 1984 Jun; 53(12):2610-4. PubMed ID: 6372981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.
    Scheithauer W; Depisch D; Kornek G; Pidlich J; Rosen H; Karall M; Prochaska M; Ernst A; Sebesta C; Eckhardt S
    Cancer; 1994 Mar; 73(6):1562-8. PubMed ID: 8156482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.